2019
DOI: 10.3389/fimmu.2019.00154
|View full text |Cite
|
Sign up to set email alerts
|

NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis

Abstract: NKG2D is an activating receptor expressed on the surface of immune cells including subsets of T lymphocytes. NKG2D binds multiple ligands (NKG2DL) whose expression are differentially triggered in a cell type and stress specific manner. The NKG2D-NKG2DL interaction has been involved in autoimmune disorders but its role in animal models of multiple sclerosis (MS) remains incompletely resolved. Here we show that NKG2D and its ligand MULT1 contribute to the pathobiology of experimental autoimmune encephalomyelitis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 43 publications
0
15
0
Order By: Relevance
“…Such expression was more apparent under inflammatory conditions. Legroux et al have now found that endogenous CD8 T cells contribute to EAE pathobiology in a NKG2D‐dependent manner; similar cytotoxic mechanisms may apply in the marmoset model of EAE (Jagessar et al, ; Legroux et al, ).…”
Section: Oligodendrocytesmentioning
confidence: 89%
See 1 more Smart Citation
“…Such expression was more apparent under inflammatory conditions. Legroux et al have now found that endogenous CD8 T cells contribute to EAE pathobiology in a NKG2D‐dependent manner; similar cytotoxic mechanisms may apply in the marmoset model of EAE (Jagessar et al, ; Legroux et al, ).…”
Section: Oligodendrocytesmentioning
confidence: 89%
“…We initially showed that human myelin (myelin basic protein [MBP] peptide) reactive CD8 T cells could induce MHC Class I restricted cytotoxicity of human OLs in vitro (Jurewicz, Biddison, & Antel, 1998 cells contribute to EAE pathobiology in a NKG2D-dependent manner; similar cytotoxic mechanisms may apply in the marmoset model of EAE (Jagessar et al, 2015;Legroux et al, 2019). (Roddy, Clark, Hazleman, Compston, & Scolding, 1994;Zajicek, Wing, Skepper, & Compston, 1995).…”
Section: Cytotoxic Cell Mediated Injurymentioning
confidence: 99%
“…By using mice with T cell–specific deficiency of NKG2D ( Klrk1 flox Cd4 Cre ), we showed that the selective deletion of NKG2D in T cells was sufficient to ameliorate EAE and arthritis, where it also mirrored the effects obtained using α-NKG2D blocking antibody. Although we cannot exclude that in EAE, within a pool of NKG2D + cells, CD8 + T cells also contribute to the pathology ( Legroux et al, 2019 ), OIA is predominantly a CD4 + T cell–mediated disease, in which CD8 + T cells play no role for the establishment of pathology ( Wong et al, 2006 ). In line with these data, the frequency of NKG2D + CD8 + T cells remained unaltered during the course of disease.…”
Section: Discussionmentioning
confidence: 99%
“…Many studies suggest that inappropriate expression of NKG2D or its ligand can cause inflammation and promote autoimmune responses, including those in diseases such as rheumatoid arthritis [ 20 ], colitis [ 21 ], Crohn’s disease [ 22 ], type 1 diabetes [ 23 ], and chronic obstructive pulmonary disease [ 24 ]. We wondered whether RAE-1, an NKG2D ligand in mice [ 25 ], would have a similar effect in PBC mice. We used immunohistochemistry to calculate the expression levels of NKG2D, RAE-1, and F4/80 and found that NKG2D expression was positively correlated with the expression of RAE-1 and F4/80 in PBC mice, a finding that we do not believe is coincidental.…”
Section: Discussionmentioning
confidence: 99%